Quest for the right Drug
אפידו EPIDUO (ADAPALENE, BENZOYL PEROXIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
עורי : DERMAL
צורת מינון:
ג'ל : GEL
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Epiduo may cause the following adverse reactions at the site of application: System Organ Class (MedDRA) Frequency Adverse Drug Reaction Not known (cannot be estimated from the Eye disorders Eyelid oedema available data)* Not known (cannot be estimated from the Immune system Anaphylactic reaction available data)* Respiratory, thoracic and mediastinal Not known (cannot be estimated from the Throat tightness, dyspnoea disorders available data)* Skin and subcutaneous tissue disorders Common (>1/100 to <1/10) Dry skin, irritative contact dermatitis, skin irritation, skin burning sensation, erythema, skin exfoliation (scaling) Uncommon (>1/1000 to <1/100) Pruritus, sunburn Not known (cannot be estimated from the Allergic contact dermatitis, swelling face, available data)* pain of skin (stinging pain), blisters (vesicles), skin discolouration (hyperpigmentation and hypopigmentation), urticaria, application site burn ** *Post marketing surveillance data **Most of the cases of "application site burn" were superficial burns but cases with second degree burn or severe burn reactions have been reported. If skin irritation appears after application of Epiduo, the intensity is generally mild or moderate, with local tolerability signs and symptoms (erythema, dryness, scaling, burning and pain of skin (stinging pain) peaking during the first week and then subsiding spontaneously. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il/
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
רישום
156 10 34289 00
מחיר
0 ₪
מידע נוסף